Article thumbnail

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

By M.C. Postorino, M. Prosperi, E. Quiros-Roldan, F. Maggiolo, S. Di Giambenedetto, A. Saracino, S. Costarelli, S. Lorenzotti, L. Sighinolfi, M. Di Pietro and C. Torti
Publisher: 'Elsevier BV'
Year: 2014
DOI identifier: 10.1016/j.cmi.2014.10.022
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.